Grimes & Company, Inc. Danaher Corp Transaction History

Grimes & Company, Inc.

$3.66 Billion
Q3 2024

A detailed history of Grimes & Company, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Grimes & Company, Inc. holds 7,347 shares of DHR stock, worth $1.75 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,347

Previous 7,342 0.07%

Holding current value

$1.75 Million

Previous $1.83 Million 11.34%

% of portfolio

0.06%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$239.25 - $280.76 $1,196 - $1,403	5 Added 0.07%	7,347 $2.04 Million
Q2 2024 Jul 22, 2024	SELL	$235.51 - $267.98 $471 - $535	-2 Reduced 0.03%	7,342 $1.83 Million
Q1 2024 Apr 17, 2024	BUY	$224.58 - $256.19 $1,572 - $1,793	7 Added 0.1%	7,344 $1.83 Million
Q4 2023 Jan 24, 2024	BUY	$185.1 - $233.13 $76,076 - $95,816	411 Added 5.93%	7,337 $1.7 Million
Q3 2023 Oct 19, 2023	SELL	$233.08 - $265.59 $13,052 - $14,873	-56 Reduced 0.8%	6,926 $1.72 Million
Q2 2023 Jul 19, 2023	BUY	$224.99 - $256.14 $7,424 - $8,452	33 Added 0.47%	6,982 $1.68 Million
Q1 2023 Apr 20, 2023	BUY	$239.75 - $277.0 $18,700 - $21,606	78 Added 1.14%	6,949 $1.75 Million
Q4 2022 Jan 25, 2023	BUY	$241.42 - $282.29 $1,207 - $1,411	5 Added 0.07%	6,871 $0
Q3 2022 Oct 28, 2022	SELL	$247.06 - $1507.4 $21,741 - $132,651	-88 Reduced 1.27%	6,866 $1.77 Million
Q2 2022 Jul 22, 2022	SELL	$237.11 - $299.66 $22,525 - $28,467	-95 Reduced 1.35%	6,954 $1.76 Million
Q1 2022 May 06, 2022	SELL	$257.27 - $315.76 $2,058 - $2,526	-8 Reduced 0.11%	7,049 $2.07 Million
Q4 2021 Feb 01, 2022	SELL	$292.08 - $329.01 $58,416 - $65,802	-200 Reduced 2.76%	7,057 $2.32 Million
Q3 2021 Nov 08, 2021	BUY	$272.21 - $332.43 $8,438 - $10,305	31 Added 0.43%	7,257 $2.21 Million
Q2 2021 Aug 04, 2021	SELL	$225.08 - $271.69 $2,250 - $2,716	-10 Reduced 0.14%	7,226 $1.94 Million
Q1 2021 May 12, 2021	BUY	$212.38 - $245.9 $174,363 - $201,883	821 Added 12.8%	7,236 $1.63 Million
Q4 2020 Feb 02, 2021	SELL	$212.5 - $245.46 $6,375 - $7,363	-30 Reduced 0.47%	6,415 $1.43 Million
Q3 2020 Nov 12, 2020	BUY	$177.16 - $215.33 $708 - $861	4 Added 0.06%	6,445 $1.39 Million
Q3 2019 Nov 05, 2019	SELL	$135.4 - $146.47 $18,008 - $19,480	-133 Reduced 2.02%	6,441 $930,000
Q2 2019 Jul 30, 2019	BUY	$124.88 - $143.73 $11,738 - $13,510	94 Added 1.45%	6,574 $940,000
Q1 2019 May 02, 2019	SELL	$97.62 - $132.29 $56,521 - $76,595	-579 Reduced 8.2%	6,480 $855,000
Q3 2018 Nov 09, 2018	BUY	$98.13 - $108.9 $53,971 - $59,895	550 Added 8.45%	7,059 $767,000
Q2 2018 Aug 10, 2018	SELL	$96.1 - $103.24 $4,805 - $5,162	-50 Reduced 0.76%	6,509 $642,000
Q1 2018 May 07, 2018	BUY	$92.16 - $103.8 $604,477 - $680,824	6,559 New	6,559 $642,000

Others Institutions Holding DHR

# of Institutions

2,510

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Danaher Corp Transaction History